SE309779B - - Google Patents

Info

Publication number
SE309779B
SE309779B SE2730/64A SE273064A SE309779B SE 309779 B SE309779 B SE 309779B SE 2730/64 A SE2730/64 A SE 2730/64A SE 273064 A SE273064 A SE 273064A SE 309779 B SE309779 B SE 309779B
Authority
SE
Sweden
Application number
SE2730/64A
Inventor
H Wuest
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262846A external-priority patent/US3192200A/en
Application filed by Warner Lambert Pharmaceutical filed Critical Warner Lambert Pharmaceutical
Publication of SE309779B publication Critical patent/SE309779B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE2730/64A 1963-03-05 1964-03-05 SE309779B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262846A US3192200A (en) 1963-03-05 1963-03-05 1-cycloalkyl methyl derivatives of 1, 4-benzodiazepine
US410790A US3326757A (en) 1963-03-05 1964-11-12 Compositions and method for producing skeletal muscle relaxation

Publications (1)

Publication Number Publication Date
SE309779B true SE309779B (en:Method) 1969-04-08

Family

ID=26949494

Family Applications (1)

Application Number Title Priority Date Filing Date
SE2730/64A SE309779B (en:Method) 1963-03-05 1964-03-05

Country Status (8)

Country Link
US (1) US3326757A (en:Method)
BE (1) BE644705A (en:Method)
BR (1) BR6457243D0 (en:Method)
CH (1) CH427830A (en:Method)
DE (1) DE1470422A1 (en:Method)
FR (1) FR3452M (en:Method)
GB (1) GB1029741A (en:Method)
SE (1) SE309779B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778264B2 (en) 2010-10-28 2014-07-15 Guy L. McClung, III Fluid treatment systems
US8911676B2 (en) 2010-10-21 2014-12-16 Guy L. McClung, III Treatment systems for fluids

Also Published As

Publication number Publication date
FR3452M (fr) 1965-07-26
US3326757A (en) 1967-06-20
DE1470422A1 (de) 1969-11-13
GB1029741A (en) 1966-05-18
CH427830A (de) 1967-01-15
BE644705A (en:Method) 1964-09-04
BR6457243D0 (pt) 1973-07-17

Similar Documents

Publication Publication Date Title
AR142945A1 (en:Method)
AT260747B (en:Method)
BE608372A (en:Method)
BE640480A (en:Method)
BE644587A (en:Method)
BE644481A (en:Method)
SE309779B (en:Method)
BE644384A (en:Method)
BE643163A (en:Method)
BE642903A (en:Method)
BE642872A (en:Method)
BE614220A (en:Method)
BE612803A (en:Method)
BE645922A (en:Method)
BE31062A (en:Method)
BE462764A (en:Method)
BE465565A (en:Method)
BE507458A (en:Method)
BE533484A (en:Method)
BE547422A (en:Method)
BE571209A (en:Method)
BE582314A (en:Method)
BE603935A (en:Method)
BE627025A (en:Method)
BE627023A (en:Method)